An animal model of neonatal cytomegalovirus infection

Antiviral Research

Volumn 60, Issue 1, 2003, Pages 41-49

  Bravo, Fernando J ^a   Bourne, Nigel ^a,b   Schleiss, Mark R ^a   Bernstein, David I ^a  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

Author keywords

Animal model; cHPMPC; Congenital CMV; Guinea pig cytomegalovirus; Neonatal CMV

Indexed keywords

ANTIVIRUS AGENT; CIDOFOVIR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; DISEASE MARKER; DRUG SCREENING; GUINEA PIG; INOCULATION; LIVER; LUNG; MALE; MORTALITY; NEWBORN INFECTION; NONHUMAN; PATHOGENESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SPLEEN; STATISTICAL SIGNIFICANCE; VIRUS ISOLATION; VIRUS LOAD; VIRUS REPLICATION; VIRUS TITRATION; VIRUS VIRULENCE; WEIGHT GAIN;

ANIMALIA; CAVIA; CAVIA PORCELLUS; CUCUMBER MOSAIC VIRUS; CYTOMEGALOVIRUS; GUINEA PIG CYTOMEGALOVIRUS; SUS SCROFA;

EID: 0141456033     PISSN: 01663542     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-3542(03)00151-7     Document Type: Article

References (38)

1. Alford, C.A., Britt, W.J., 1993. Cytomegalovirus. In: Roizman, B., Whitley, R.J., Lopez, C. (Eds.), The Human Herpesviruses. Raven Press, New York, pp. 227-255.
2. Bale J.F., Miner L., Petheram S.J. Congenital cytomegalovirus infection. Curr. Treat. Options Neurol. 4:2002;225-230.
3. Ballard R.B., Drew W.L., Hufnagle K.G., Riedel P.A. Acquired cytomegalovirus infection in preterm infants. Am. J. Dis. Child. 133:1979;482-485.
4. Bernstein, D.I., Bourne, N., 1999. Animal models for cytomegalovirus infection: guinea-pig CMV. In: Zak, O., Sande, M.E. (Eds.), Handbook of Animal Models of Infection. Academic Press, San Diego, pp. 935-941.
5. Bia F.J., Lucia H.L., Fong C.K., Tarsio M., Hsuing G.D. Effects of vaccination on cytomegalovirus-associated interstitial pneumonia in strain 2 guinea pigs. J. Infect. Dis. 145:1982;742-747.
6. Bia F.J., Miller S.A., Lucia H.L., Griffith B.P., Tarsio M., Hsiung G.D. Vaccination against transplacental cytomegalovirus transmission: vaccine reactivation and efficacy in guinea pigs. J. Infect. Dis. 149:1984;355-362.
7. Bischofberger N., Hitchcock M.J., Chen M.S., Barkhimer D.B., Cundy K.C., Kent K.M., Lacy S.A., Lee W.A., Li Z.H., Mendel D.B. 1-[((S)-2-Hydroxy-oxo-1,4,2,-dioxaphosphorinan-5-yl)methyl]cytosine, an intracellular prodrug for (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine with improved therapeutic index in vivo. Antimicrob. Agents Chemother. 38:1994;2387-2391.
8. Boppana S.B., Pass R.F., Britt W.J., Stagno S., Alford C.A. Symptomatic congenital cytomegalovirus infection: neonatal morbidity and mortality. Pediatr. Infect. Dis. J. 11:1992;93-99.
9. Bourne N., Bravo F.J., Bernstein D.I. Cyclic HPMPC is safe and effective against systemic guinea pig cytomegalovirus infection in immune compromised animals. Antiviral Res. 47:2000;103-109.
10. Bourne N., Schleiss M.R., Bravo F.J., Bernstein D.I. Preconception immunization with a cytomegalovirus (CMV) glycoprotein vaccine improves pregnancy outcome in a guinea pig model of congenital CMV infection. J. Infect. Dis. 183:2001;59-64.
11. Bratcher D.F., Bourne N., Bravo F.J., Schleiss M.R., Slaoui M., Myers M.G., Bernstein D.I. Effect of passive antibody on congenital cytomegalovirus infection in guinea pigs. J. Infect. Dis. 172:1995;944-950.
12. Bravo F.J., Stanberry L.R., Kier A.B., Vogt P.E., Kern E.R. Evaluation of HPMPC therapy for primary and recurrent genital herpes in mice and guinea pigs. Antiviral Res. 21:1993;59-72.
13. Chatterjee A., Harrison C.J., Britt W.J., Bewtra C. Modification of maternal and congenital cytomegalovirus infection by anti-glycoprotein B antibody transfer in guinea pigs. J. Infect. Dis. 183:2001;1547-1553.
14. Dahle A.J., Fowler K.B., Wright J.D., Boppana S.B., Britt W.J., Pass R.F. Longitudinal investigation of hearing disorders in children with congenital cytomegalovirus. J. Am. Acad. Audiol. 11:2000;283-290.
15. de Cates C.R., Gray J., Roberton N.R.C., Walker J. Acquisition of cytomegalovirus infection by premature infants. J. Infect. 28:1994;25-30.
16. Demmler G.J. Infectious Diseases Society of America and Centers for Disease Control. Summary of a workshop on surveillance for congenital cytomegalovirus diseases. Rev. Infect. Dis. 13:1991;315-329.
17. Gaytant M.A., Steegers E.A., Semmekrot B.A., Merkus H.M., Galama J.M. Congenital cytomegalovirus infection: review of the epidemiology and outcome. Obstet. Gynecol. Surv. 57:2002;245-256.
18. Griffith B.P., Lavallee J.T., Jennings T.A., Hsiung G.D. Transmission of maternal cytomegalovirus-specific immunity in the guinea pig. Clin. Immunol. Immunopathol. 35:1985;169-181.
19. Hamprecht K., Maschmann J., Vochem M., Dietz K., Speer C.P., Jahn G. Epidemiology of transmission of cytomegalovirus from mother to preterm infant by breastfeeding. Lancet. 357(9255):2001;513-518.
20. Harrison C.J., Myers M.G. Peripheral blood mononuclear cell-mediated cytolytic activity during cytomegalovirus (CMV) infection of guinea pigs. J. Med. Virol. 25:1988;441-453.
21. Harrison C.J., Britt W.J., Chapman N.M.et al. Reduced congenital cytomegalovirus (CMV) infection after maternal immunization with a guinea pig CMV glycoprotein before gestational primary infection in the guinea pig model. J. Infect. Dis. 172:1995;1212-1220.
22. Hickson L.M., Alcock D. Progressive hearing loss in children with congenital cytomegalovirus. J. Pediatr. Child. Health. 27:1991;105-107.
23. Kern E.R. Value of animal models to evaluate agents with potential activity against human cytomegalovirus. Transplant. Proc. 23:1991;152-155.
24. Kimberlin, D.W., Lin, C.Y., Sanchez, P., 2000. Ganciclovir treatment of symptomatic congenital CMV infections: results of a phase III randomized trial. In: 40th ICAAC Abstracts, Toronto, Canada (abstract # 1942).
25. Kumar M.L., Nankervis G., Cooper A.R., Gold E. Postnatally acquired cytomegalovirus infections in infants of CMV-excreting mothers. J. Pediatr. 104:1984;669-673.
26. Mani C.S., Bravo F.J., Stanberry L.R., Myers M.G., Bernstein D.I. Effect of age and route of inoculation on outcome of neonatal herpes simplex virus infection in guinea pigs. J. Med. Virol. 48:1996;247-252.
27. Schleiss M.R. Cytomegalovirus in immunocompromised persons. Curr. Treat. Options Infect. Dis. 4:2002;43-50.
28. Schleiss M.R., McGregor A., Jensen N., Erdem G., Atkan L. Molecular characterization of the guinea pig cytomegalovirus UL83 (pp65) protein homolog. Virus Genes. 19:1999;205-221.
29. Shanley J.D., Biczak L., Forman S.J. Acute murine cytomegalovirus infection induces lethal hepatitis. J. Infect. Dis. 167:1993;264-269.
30. Stagno S., Reynolds D.W., Pass R.F., Alford C.A. Breast milk and the risk of cytomegalovirus infection. New Engl. J. Med. 302:1980;1073-1076.
31. Stagno S., Brasfield D.M., Brown M.B., Cassell G.H., Pifer L.L., Whitley R.J., Tiller R.E. Infant pneumonitis associated with cytomegalovirus chlamydia pneumocystis and ureaplasma - a prospective study. Pediatrics. 68:1981;322-329.
32. Stals F.S., Bosman F., van Boven C.P., Bruggeman C.A. An animal model for therapeutic intervention studies of CMV infection in the immunocompromised host. Arch. Virol. 114:1990;91-107.
33. Stratton, K.R., Durch, J.S., Lawrence, R.S., 2001. Vaccines for the 21st Century: A Tool For Decision Making. National Academy Press, Washington, DC.
34. Vochem M., Hamprecht K., Jahn G., Speer C.P. Transmission of cytomegalovirus to preterm infants through breast milk. Pediatr. Infect. Dis. J. 17:1998;53-58.
35. Whitley R.J., Brasfield D., Reynolds D.W.et al. Protracted pneumonitis in young infants associated with perinatally acquired cytomegalovirus infection. J. Pediatr. 89:1976;16-22.
36. Whitley R.J., Cloud G., Gruber W., Storch G.A., Demmler G.J., Jacobs R.F., Dankner W., Spector S.A., Starr S., Pass R.F., Stagno S.A., Britt W.J., Alford C., Soong S., Zhou X.J., Sherrill L., Fitzgerald J.M., Sommadossi J.P. Ganciclovir treatment of symptomatic congenital cytomegalovirus infection: results of a phase II study. National Institute of Allergy and Infectious Diseases Collaborative Study Group. J. Infect. Dis. 175:1997;1080-1086.
37. Yeager A.S., Palumbo P.E., Malachowsky N., Ariagno R.L., Stevenson D.K. Sequelae of maternally derived cytomegalovirus infections in premature infants. J. Pediatr. 102:1983;918-922.
38. Zheng Z.M., Lavalle J.T., Bia F.J., Griffith B.P. Thymic hypoplasia, splenomegaly and immune depression in guinea pigs with neonatal cytomegalovirus infection. Dev. Comp. Immunol. 11:1987;407-418.